Posted by Michael Wonder on 18 Dec 2020
FDA approves first oral hormone therapy for treating advanced prostate cancer
18 December 2020 - Today, the U.S. FDA approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
The safety and efficacy of Orgovyx was evaluated in a randomised, open-label trial in men with advanced prostate cancer.
